PofoliaShared via Pofolia

Eurosurveillance· 2020Q1

Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR

Victor M. Corman, Olfert Landt, Marco Kaiser, Richard Molenkamp et al.

Short summary

A validated real-time RT-PCR diagnostic workflow for the novel 2019-nCoV has been developed and deployed, capable of detecting the virus and distinguishing it from SARS-CoV without requiring live virus samples.

AI-generated from the title and abstract; the full text is not read.

Key points

  • Developed a real-time RT-PCR diagnostic workflow for 2019-nCoV.
  • Workflow uses synthetic nucleic acid technology, not requiring live virus isolates.
  • Assay reliably detects 2019-nCoV and distinguishes it from SARS-CoV.
  • Exclusivity confirmed using 297 clinical specimens with a spectrum of respiratory viruses.

AI-generated from the title and abstract; the full text is not read.

Abstract

BACKGROUND: The ongoing outbreak of the recently emerged novel coronavirus (2019-nCoV) poses a challenge for public health laboratories as virus isolates are unavailable while there is growing evidence that the outbreak is more widespread than initially thought, and international spread through travellers does already occur. AIM: We aimed to develop and deploy robust diagnostic methodology for use in public health laboratory settings without having virus material available. METHODS: Here we present a validated diagnostic workflow for 2019-nCoV, its design relying on close genetic relatedness of 2019-nCoV with SARS coronavirus, making use of synthetic nucleic acid technology. RESULTS: The workflow reliably detects 2019-nCoV, and further discriminates 2019-nCoV from SARS-CoV. Through coordination between academic and public laboratories, we confirmed assay exclusivity based on 297 original clinical specimens containing a full spectrum of human respiratory viruses. Control material is made available through European Virus Archive - Global (EVAg), a European Union infrastructure project. CONCLUSION: The present study demonstrates the enormous response capacity achieved through coordination of academic and public laboratories in national and European research networks.

The authors' abstract, as published at the source. Eurosurveillance, 2020 · DOI ↗

TakeawaysPremium
Ask the paperFree account

Continue with a free account

Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.

Continue free on the web

Sign in with Google or Apple; no card needed. You come back to this paper.

On your phone:

Field: Infectious Diseases

Infectious DiseasesMedicine